Theranos lab may pose threat to patient safety, regulator says

Violations at a laboratory run by Theranos could put patient safety at risk, CMS says. According to CMS, the lab violated several clinical standards and has 10 days to resolve the issues. Of particular concern was Theranos’ hematology testing, as the company’s failure to meet regulators’ clinical standards could threaten patient safety. The tests typically include red and white blood cell counts and monitoring of patients taking blood thinners.